AbbVie Inc. CDR (ABBV)
NEO
Closed
Aug 21, 2026
Day's Range
36.5052 wk Range
26.89Overview - ABBV - AbbVie Inc. CDR
Key Statistics
Valuation
Enterprise Value
164.81B
P/E (Trailing)
‪194.36‬
PEG Ratio
‪0.68‬
Price / Sales (TTM)
‪10.80‬
Price / Book
‪-104.83‬
EV / EBITDA
‪4.06‬
Profitability
Gross Margin
‪74.74%‬
Profit Margin
‪4.00%‬
Operating Margin
‪35.49%‬
Return on Assets
‪9.58%‬
Return on Equity
‪137.96%‬
Ownership
Shares Outstanding
1.76B
Float
1.76B
Short % of Shares Outstanding
‪0.00%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪32.08‬
200-Day Avg
‪29.30‬
Dividends
Payout Ratio
‪476.63%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - ABBV - AbbVie Inc. CDR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NEO.
- ABBVNEOAbbVie Inc. CDR603.71BMarket Cap+20.86%52-week change182.11P/E (Trailing)‪4.00%‬Profit Margin
- ROCHNEORoche Holding Ltd.472.53BMarket Cap+28.63%52-week change10.18P/E (Trailing)‪19.60%‬Profit Margin
- NVSNEONovartis AG437.73BMarket Cap+25.62%52-week change18.81P/E (Trailing)‪24.74%‬Profit Margin
- AMGNNEOAmgen Inc. Canadian Depositary Receipt275.72BMarket Cap+18.43%52-week change33.21P/E (Trailing)‪17.38%‬Profit Margin
- GILDNEOGilead Sciences Inc. CDR221.12BMarket Cap+11.69%52-week change20.59P/E (Trailing)‪27.88%‬Profit Margin
- ZLLYNEOEli Lilly and Company Canadian Depositary Receipt11.63BMarket Cap+13.72%52-week change0.33P/E (Trailing)‪34.98%‬Profit Margin
Profile Summary - ABBV - AbbVie Inc. CDR
About
AbbVie Inc. CDR is a Canadian Depositary Receipt that provides Canadian investors with exposure to AbbVie Inc., a research-based biopharmaceutical company, trading in Canadian dollars with a currency hedge to minimize foreign exchange risk. AbbVie Inc. engages in the discovery, development, manufacturing, and sale of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
